403-20-3

Basic information

• Product Name: 3-Fluoro-4-methoxybenzoic acid
• Synonyms: RARECHEM AL BO 0870;TIMTEC-BB SBB006649;BUTTPARK 45\01-63;3-FLUORO-P-ANISIC ACID;3-FLUORO-4-METHOXYBENZOIC ACID;3-Fluoro-4-methoxybenzoic acid 98%;3-Fluoro-4-methoxybenzoicacid98%;4-Carboxy-2-fluoroanisole, 3-Fluoro-p-anisic acid
• CAS NO: 403-20-3
• Molecular Formula: C₈H₇FO₃
• Molecular Weight: 170.14
• EINECS: -0
• Product Categories: Aromatic Carboxylic Acids, Amides, Anilides, Anhydrides & Salts;Acids & Esters;Anisoles, Alkyloxy Compounds & Phenylacetates;Fluorine Compounds;C8;Carbonyl Compounds;Carboxylic Acids;Fluorine series
• Mol File: 403-20-3.mol
• Article Data: 11

Chemical Properties

• Melting Point: 211-213 °C(lit.)
• Boiling Point: 286.4 °C at 760 mmHg
• Flash Point: 127 °C
• Appearance: white to off-white crystalline powder
• Density: 1.2708 (estimate)
• Vapor Pressure: 0.00124mmHg at 25°C
• Storage Temp.: Sealed in dry,Room Temperature
• PKA: 4.13±0.10(Predicted)
• BRN: 2087583
• CAS DataBase Reference: 3-Fluoro-4-methoxybenzoic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 3-Fluoro-4-methoxybenzoic acid(403-20-3)
• EPA Substance Registry System: 3-Fluoro-4-methoxybenzoic acid(403-20-3)

Safety Data

• Hazard Codes: Xi
• Statements: 36/37/38
• Safety Statements: 37/39-26-24/25
• WGK Germany: 3
• HazardClass: IRRITANT
• Hazardous Substances Data: 403-20-3(Hazardous Substances Data)

Usage

Chemical Properties

white to off-white crystalline powder

InChI:InChI=1/C8H7FO3/c1-12-7-3-2-5(8(10)11)4-6(7)9/h2-4H,1H3,(H,10,11)/p-1

Upstream product

• 109-72-8 n-butyllithium 
• 2357-52-0 3-fluoro-4-methoxyphenyl bromide 
• 351-54-2 3-fluoro-p-anisaldehyde 
• 89-41-8 4-methoxy-3-nitrobenzoic acid 
• 399-55-3 2-fluoro-1-methoxy-4-methylbenzene 
• 74-83-9 methyl bromide 
• 350-29-8 3-fluoro-4-hydroxybenzoic acid 
• 2105-94-4 4-bromo-2-fluorophenol 
• 321-28-8 1-fluoro-2-methoxybenzene 
• 331-62-4 3-fluoro-4-methoxybenzonitrile 
• 124-38-9 carbon dioxide 
• 96047-32-4 3-fluoro-4-methoxybenzyl alcohol 
• 403-14-5 3-fluoro-4-hydroxyacetophenone 
• 29650-44-0 2-fluorophenyl acetate 

Downstream Products

• 62578-22-7 C₂₃H₂₈F₂N₂O₄ 
• 3907-15-1 3-fluoro-4-methoxybenzoylchloride 
• 364-28-3 3-fluoro-4-methoxy-5-nitro-benzoic acid methyl ester 
• 329-46-4 3-amino-5-fluoro-4-methoxy-benzoic acid methyl ester 
• 544704-74-7 2-bromo-6-[(3-fluoro-4-methoxybenzoyl)amino]-4-methoxyphenyl-3-fluoro-4-methoxybenzoate 
• 701640-04-2 3-fluoro-4-methoxy-benzamide 
• 1018069-77-6 3-fluoro-4-methoxy-N-(1-{[7-(methoxymethyl)-2-naphthyl]methyl}piperidin-4-yl)benzamide 
• 1259307-60-2 3-(3-fluoro-4-methoxybenzoyl)-9-methyl-3,9-diazaspiro[5.5]undecane trifluoroacetic acid salt 
• 1227870-22-5 4-(4-pentylbenzoyloxy)-3-fluorobenzoic acid 
• 1227870-16-7 4-cyano-3-fluorophenyl 4-(4-pentylbenzoyloxy)-3-fluorobenzoate 
• 1227870-15-6 4-cyanophenyl 4-(4-pentylbenzoyloxy)-3-fluorobenzoate 
• 1227870-17-8 4-cyano-3,5-difluorophenyl 4-(4-pentylbenzoyloxy)-3-fluorobenzoate 
• 1227870-18-9 3,4-difluorophenyl 4-(4-pentylbenzoyloxy)-3-fluorobenzoate 
• 1227870-19-0 benzyl 4-(4-pentylbenzoyloxy)-3-fluorobenzoate 

Relevant articles and documents

Sodium copper chlorophyllin catalyzed chemoselective oxidation of benzylic alcohols and diarylmethanes in water

We report the highly efficient and chemoselective oxidation of benzylic alcohols catalyzed by sodium copper chlorophyllin in water, producing corresponding arylcarbonyl compounds. Importantly, the catalytic system exhibits a wide substrate scope and high functional group tolerance. Moreover, secondary alcohols and even diarylmethanes were smoothly oxidized to the desired aryl ketones with excellent yields.

NOVEL ARYLALKENE DERIVATIVES AND USE THEREOF AS SELECTIVE ESTROGEN RECEPTOR MODULATORS

The invention provides novel ethylene derivatives represented by Formula I, which may be used as selective estrogen receptor modulators (SERMs) and useful in the prophylaxis and/or treatment of estrogen-dependent conditions or conditions.

TROPANE COMPOUNDS

A compound according to Formula I or II: (I) or (II) wherein R1, R1b, R2, L1, and L2 and L2b are as defined in the specification, pharmaceutical compositions thereof, and methods of use thereof.